Regulatory

Regulatory  ·  Weekly Digest 05 July to 11 July 2025
U.S. FDA grants orphan drug designation to Adcentrx Therapeutics’ ADRX-0405 STEAP1 ADC for gastric cancer

Weekly Digest – July 2025 Weekly Digest – July 2025 08 July 2025: U.S. FDA grants orphan drug designation to Adcentrx Therapeutics’ ADRX-0405 STEAP1 ADC for gastric cancer The U.S. FDA granted orphan drug designation to Adcentrx Therapeutics ADC candidate […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 05 July to 11 July 2025
Henlius receives global regulatory approvals for Phase 2 MRCT of its PD-L1 ADC HLX43 on NSCLC

Weekly Digest – July 2025 Weekly Digest – July 2025 09 July 2025: Henlius receives global regulatory approvals for Phase 2 MRCT of its PD-L1 ADC HLX43 on NSCLC  Henlius received regulatory approvals from China (NMPA), U.S. (FDA), Australia (TGA), […]

by Sandhya Ramalingam

Continue Reading